Evidence map›Paper›PMID 28687042›Full record

ArticleACS chemical biology2017

Discovery of Heteroaromatic Sulfones As a New Class of Biologically Compatible Thiol-Selective Reagents.

Xiaofei Chen, Hanzhi Wu, Chung-Min Park, Thomas H Poole, Gizem Keceli, Nelmi O Devarie-Baez, Allen W Tsang, W Todd Lowther, Leslie B Poole, S Bruce King and 2 more

Abstract read
In one paragraph

Article in ACS chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fast Cysteine Bioconjugation Chemistry.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  10. A modular template for the design of thiol-triggered sensors and prodrugs.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Arylation Chemistry for Bioconjugation.Angewandte Chemie (International ed. in English) · 2019
    Review
  16. Article
  17. Mass Spectrometry in Advancement of Redox Precision Medicine.Advances in experimental medicine and biology · 2019
    Review
  18. HThe Journal of biological chemistry · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaofei ChenDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
Hanzhi WuDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
Chung-Min ParkDepartment of Chemistry, Washington State University , Pullman, Washington 99164, United States.
Thomas H PooleDepartment of Chemistry, Wake Forest University , Winston-Salem, North Carolina 27109, United States.
Gizem KeceliDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.ORCID 0000-0002-9562-7994
Nelmi O Devarie-BaezDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
Allen W TsangDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
W Todd LowtherDepartment of Biochemistry, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
Leslie B PooleDepartment of Biochemistry, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.
S Bruce KingDepartment of Chemistry, Wake Forest University , Winston-Salem, North Carolina 27109, United States.
Ming XianDepartment of Chemistry, Washington State University , Pullman, Washington 99164, United States.ORCID 0000-0002-7902-2987
Cristina M FurduiDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine , Winston-Salem, North Carolina 27157, United States.ORCID 0000-0003-3771-7999

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Structures &Redox Chemistry in Sulfinic Acid ReductionR01GM072866 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LOWTHER, W TODD · 2005 to 2014
$2.6M
Novel Sulfide Releasing Agents for Ischemic InjuryR01HL116571 · NHLBI · WASHINGTON STATE UNIVERSITY · PI LEFER, DAVID JOSEPH, XIAN, MING · 2014 to 2017
$1.8M
New Oxidation-Sensing Probes to Evaluate Mitochondrial Dysfunction in Lung InjuryR33ES025645 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FURDUI, CRISTINA MARIA, KING, S BRUCE · 2017 to 2019
$1.5M
New Reagents for Tracking Protein Oxidation in Cells by MS and Imaging MethodsR33CA177461 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FURDUI, CRISTINA MARIA, POOLE, LESLIE B · 2013 to 2015
$1.0M
New Oxidation-Sensing Probes to Evaluate Mitochondrial Dysfunction in Lung InjuryR21ES025645 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FURDUI, CRISTINA MARIA, KING, S BRUCE · 2015 to 2016
$428k
NCI NIH HHS P30 CA012197NCI NIH HHS R33 CA177461NHLBI NIH HHS R01 HL116571NIEHS NIH HHS R21 ES025645NIEHS NIH HHS R33 ES025645
6 · The paper itself

Abstract

The selective reaction of chemical reagents with reduced protein thiols is critical to biological research. This reaction is utilized to prevent cross-linking of cysteine-containing peptides in common proteomics workflows and is applied widely in discovery and targeted redox investigations of the mechanisms underlying physiological and pathological processes. However, known and commonly used thiol blocking reagents like iodoacetamide, N-ethylmaleimide, and others were found to cross-react with oxidized protein sulfenic acids (-SOH) introducing significant errors in studies employing these reagents. We have investigated and are reporting here a new heteroaromatic alkylsulfone, 4-(5-methanesulfonyl-[1,2,3,4]tetrazol-1-yl)-phenol (MSTP), as a selective and highly reactive -SH blocking reagent compatible with biological applications.

Indexed as

Drug DiscoveryCell Line, TumorCell MembraneHumansMass SpectrometryModels, BiologicalMolecular StructurePhenolsSulfhydryl ReagentsSulfonesTetrazoles4-(5-methanesulfonyl-(1,2,3,4)tetrazol-1-yl)-phenolPhenolsSulfhydryl ReagentsSulfonesTetrazoles

Identifiers

PMID28687042
PMCPMC5658784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.